Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

MNG760

273f8380-522e-55dd-9d4c-f6193a243308

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • OXIDATIVE_PHOSPHORYLATION+0.297
  • PANCREAS_BETA_CELLS+0.186
  • NOTCH_SIGNALING+0.057
  • KRAS_SIGNALING_DN+0.036
  • MYC_TARGETS_V1+0.028
  • UV_RESPONSE_UP-0.011
  • APICAL_JUNCTION-0.020
  • ADIPOGENESIS-0.021
  • SPERMATOGENESIS-0.025
  • CHOLESTEROL_HOMEOSTASIS-0.030

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.565
  • TNFA_SIGNALING_VIA_NFKB-0.519
  • INTERFERON_GAMMA_RESPONSE-0.507
  • IL6_JAK_STAT3_SIGNALING-0.457
  • HYPOXIA-0.382
  • ALLOGRAFT_REJECTION-0.381
  • APOPTOSIS-0.372
  • MITOTIC_SPINDLE-0.367
  • INFLAMMATORY_RESPONSE-0.346
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.334

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR10899984
melanoma-umap@29
0.886
2MNG199
mng-umap@100
0.883
3SRR4296068
lung-landscapes@6
cohortA10.879
4TCGA-37-4129-01A-01R-1100-07
lung-landscapes@6
cohortSC0.875
5TCGA-E9-A245-01A-22R-A16F-07
breast-umap@18
B0.862
6MNG341
mng-umap@100
0.857
7SRR1516072
bladder-landscape@3
0.856
8TCGA-E5-A4U1-01A-11R-A31N-07
bladder-landscape@3
0.856
9c8b9a438-4194-4243-a738-4e0bd4184f19
melanoma-umap@29
0.856
10MNG604
mng-umap@100
0.855

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 5 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
OXIDATIVE_PHOSPHORYLATION0.297Remibrutinib— uncovered
PANCREAS_BETA_CELLS0.186Cobimetinib— uncovered
NOTCH_SIGNALING0.057Inavolisib— uncovered
KRAS_SIGNALING_DN0.036Remibrutinib— uncovered
MYC_TARGETS_V10.028Inavolisib— uncovered